Rani Therapeutics Holdings, Inc. · NASDAQ:RANI
Javadi Alireza sold 386 Rani Therapeutics Holdings, Inc. shares (Form 4)
Traded Mar 27 to Jun 27, 2026 · Filed Jul 21, 2026
From Mar 27 to Jun 27, 2026, Javadi Alireza (Chief Technical Officer) sold 386 Rani Therapeutics Holdings, Inc. shares at US$0.78 for US$301, leaving 9,380 shares. Filed Jul 21, 2026 (Form 4).
- Sold
- 386 shares
- Price
- US$0.78
- Value
- US$301
- Holding after
- 9,380 shares
- Trading plan
- No
- Role
- Chief Technical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Mar 27, 2026 | Class A Common Stock | Sale | 386 | US$0.78 | 9,689 | Direct |
| Jun 27, 2026 | Class A Common Stock | Shares withheld for tax | 309 | US$0.74 | 9,380 | Direct |
Source
Related
- Rani Therapeutics Holdings, Inc.
- Javadi Alireza
- Rani Therapeutics Holdings, Inc. shareholders
- Form 4 · Javadi Alireza · Sep 29, 2026
- Form 4 · Imran Talat · Sep 29, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Imran Mir A · Jul 23, 2026
- Form 4 · Imran Talat · Jul 21, 2026